GM Crop Database

Database Product Description

MON87712 (MON-87712-4)
Host Organism
Glycine max (Soybean)
Yield Increase
Trait Introduction
Agrobacterium tumefaciens-mediated plant transformation.
Proposed Use

Production for human consumption and livestock feed.

Product Developer
Monsanto Company

Summary of Regulatory Approvals

Country Food Feed Environment Notes
Canada 2013 2013 2013
United States 2013 2013 2013

Introduction Expand

MON 87712 is soybean line developed by Monsanto. The introduced trait leads to an increased yield compared to its conventional counterpart. This line was developed from conventional soybean line A3525 through Agrobacterium-mediated transformation through which the BBX32 coding sequence derived from Arabidopsis thaliana was introduced into A3525 to produce the BBX32, a protein involved in dark-to-light transition. This modulation of diurnal metabolism in the soybean plant results in the increased yield potential.

Summary of Introduced Genetic Elements Expand

Code Name Type Promoter, other Terminator Copies Form
CP4 epsps 5-enolpyruvyl shikimate-3-phosphate synthase SM

the FMV/EF-1α promoter, EF-1α leader, EF-1α intron, CTP2 targeting sequence

the E9 3′ untranslated region


Selectable marker, not in the GE plant


The e35S promoter

The E6 3′ untranslated region


Characteristics of Glycine max (Soybean) Expand

Center of Origin Reproduction Toxins Allergenicity

Southeast Asia; wild soybean species endemic in China, Korea, Japan, Taiwan.

Self-polinated; rarely displays any dormancy characteristics; does not compete well with other cultivated plants.

Raw soybeans contain trypsin inhibitors, which are toxin when eaten.

Soy allergies are common, and eating soy products can cause rashes and swelling of the skin in sensitive individuals.

Donor Organism Characteristics Expand

Latin Name Gene Pathogenicity
Agrobacterium tumefaciens strain CP4 CP4 epsps

Agrobacterium tumefaciens is a common soil bacterium that is responsible for causing crown gall disease in susceptible plants. There have been no reports of adverse effects on humans or animals.

Arabidopsis thaliana BBX32

A. thaliana is not known to be a human or animal pathogen. There is evidence that researchers working with the plant may develop occupational allergies.

Modification Method Expand

Coming soon.

Characteristics of the Modification Expand

Coming soon.

Environmental Safety Considerations Expand

Coming soon.

Food and/or Feed Safety Considerations Expand

Coming soon.

Links to Further Information Expand

This record was last modified on Monday, January 9, 2017